Log in to your Inderes Free account to see all free content on this page.
Nanoform Finland
1.06 EUR
-0.38 %
3,646 following
NANOFH
First North Finland
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-0.38 %
-0.56 %
+29.89 %
+21.38 %
-23.92 %
-14.84 %
-67.71 %
-78.67 %
-79.09 %
Nanoform Finland operates in the medical technology sector. The company specializes in research and development of nanoparticle technology used to create nanoparticles in pharmaceuticals. The technology is used as a complement in the production process and is used for the treatment of diseases such as ALS and Alzheimer's. Customers consist of players in the global pharmaceutical industry, with the largest operations in the Nordic market. Nanoform Finland is headquartered in Helsinki.
Read moreMarket cap
90.47M EUR
Turnover
99.98K EUR
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26.2.
2026
Annual report '25
All
Research
Webcasts
Press releases
ShowingAll content types
Life Science Companies as Investments | Life Science Night Dec. 9, 2025
Nanoform Capital Markets Day December 16th, 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio